This study aimed to evaluate the therapeutic efficacy of the cisplatin encapsulated into
polybutylcyanoacrylate (PBCA) nanoparticles for the treatment of kidney cancer. The …

Nano-drug delivery holds great potential to enhance the efficacy of carboplatin. This study
focused on cytotoxicity, in vitro drug release and characterization of poly (butyl …

This study aims to improve the cytotoxicity and potency of cisplatin-loaded
polybutylcyanoacrylate (PBCA) nanoparticles (NPs) for the treatment of lung cancer through …

Background: This study aimed to develop a novel drug formulation using
polybutylcyanoacrylate (PBCA) nanoparticles to deliver cisplatin, a commonly used …

One of the main challenges of treatment of ovarian cancer is initial response to treatment
and then acquisition of resistance to Cisplatin. Nanotechnology-based approaches are …

Glioblastoma is known as one of the most aggressive human cancers. To gain access of the
brain, therapeutic agents must overcome blood–brain barrier (BBB). In this study, Cisplatin …

Cancer is one of the most important issues in modern medicine and the most common cause
of death after cardiovascular diseases in many countries. Brain cancer is one of the most …

The manufacture of stable paclitaxel-loaded poly (n-butyl cyanoacrylate)(PBCA)
nanoparticles containing high loading and encapsulation efficiency simultaneously were …

The hyaluronic acid (HA) coated poly (butyl cyanoacrylate)(PBCA) nanoparticles were
synthesized through radical polymerization of butyl cyanoarylate (BCA) initiated by cerium …

Carboplatin is a platinum based drug used in the treatment of several malignancies. Due to
poor cellular uptake, generally, a larger dose of drug is administered to achieve therapeutic …